enGene Therapeutics (ENGN) EBITDA (2023 - 2026)
enGene Therapeutics (ENGN) posted EBITDA of -$33.91 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$29.85 million a year earlier.
Powered by 
Analysis
enGene Therapeutics (ENGN) EBITDA (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jul 31, 2026, EBITDA at enGene Therapeutics was -$135.96 million; for FY2025 (ended Oct 31, 2025), it was -$122.67 million.
- In prior fiscal years, enGene Therapeutics' EBITDA was -$62 million in FY2024, -$25.86 million in FY2023 and -$19.23 million in FY2022.
- Quarterly EBITDA has run from a low of -$39.28 million in fiscal Q4 2025 to a high of -$4.59 million in fiscal Q1 2023 over five years.
- According to Business Quant data, EBITDA for the three prior fiscal quarters was -$31.77 million (Q2 2026), -$31 million (Q1 2026) and -$39.28 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.30 Bn |
| 10 | enGene Therapeutics | 130.68 Mn | 130.68 Mn | - | -33.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -33.91 Mn |
| Apr 30, 2026 | -31.77 Mn |
| Jan 31, 2026 | -31.00 Mn |
| Oct 31, 2025 | -39.28 Mn |
| Jul 31, 2025 | -29.85 Mn |
| Apr 30, 2025 | -27.02 Mn |
| Jan 31, 2025 | -26.51 Mn |
| Oct 31, 2024 | -17.36 Mn |
| Jul 31, 2024 | -16.66 Mn |
| Apr 30, 2024 | -17.21 Mn |
| Jan 31, 2024 | -10.69 Mn |
| Oct 31, 2023 | -10.37 Mn |
| Jul 31, 2023 | -6.21 Mn |
| Apr 30, 2023 | -4.70 Mn |
| Jan 31, 2023 | -4.59 Mn |
API Access
enGene Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();